{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Recently Released Enhanced Regulatory Initiatives for Drug Compounders",
    "url": "https://www.lexblog.com/2017/10/02/recently-released-enhanced-regulatory-initiatives-for-drug-compounders/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-3BA0F5ZT",
        "url": "https://www.lexblog.com/lib/3BA0F5ZT/"
    },
    "datePublished": "2017-10-02T10:19:05-04:00",
    "dateModified": "2022-07-22T17:01:15-04:00",
    "author": {
        "@type": "Person",
        "name": "Rachael G. Pontikes, Emily L. Hussey, John D. Kendzior"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Reed Smith LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Health Industry Washington Watch",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.healthindustrywashingtonwatch.com/?p=17854",
    "sourceStability": "may-move"
}